← Browse by Condition
Medical Condition

pleural effusion

Total Trials
5
Recruiting Now
5
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for pleural effusion sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pleural effusion Clinical Trials

How many clinical trials are currently recruiting for pleural effusion?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for pleural effusion, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pleural effusion?
pleural effusion research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pleural effusion clinical trial?
Eligibility criteria for pleural effusion trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
University of Aarhus 1 trial
Guy's and St Thomas' NHS Foundation Trust 1 trial
Icahn School of Medicine at Mount Sinai 1 trial
China-Japan Friendship Hospital 1 trial
National and Kapodistrian University of Athens 1 trial

Recruiting Clinical Trials

NCT06180603
Recruiting
Strategy for Prompt and Effective Thoracentesis in the Emergency Department
Enrollment
188 pts
Location
Denmark
Sponsor
University of Aarhus
View Trial →
NCT05945043
Recruiting
Continuation Of a Study to Investigate the Effect of Thoracocentesis on Neural Respiratory Drive in Pleural Effusion
Enrollment
124 pts
Location
United Kingdom
Sponsor
Guy's and St Thomas' NHS Found...
View Trial →
NCT06892691
Recruiting
Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural Effusions
Enrollment
98 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
View Trial →
NCT06741839
Recruiting
Confocal Laser Endomicroscopy Guided Medical Thoracoscopy for the Diagnosis of Pleural Disease
Enrollment
158 pts
Location
China
Sponsor
China-Japan Friendship Hospita...
View Trial →
NCT06946498
Recruiting
First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
Enrollment
100 pts
Location
Greece
Sponsor
National and Kapodistrian Univ...
View Trial →

Related Conditions

pleural diseases (2) heart failure (1) cancer (1) suspected malignant lung neoplasm (1) pleural effusion malignant (1) mesothelioma malignant (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology